The latest in screening technology

Each year, an estimated 7.9 million babies worldwide are born with birth defects, many of whom appear healthy at birth and come from families with no history of the disorder. Many affected babies are not identified until the appearance of severe and often irreversible symptoms later in life.
Detecting a disease at an early stage can enable appropriate and timely medical intervention before more serious and sometimes irreversible health issues are caused.
BGI’s NOVA™ Newborn Genetic Screening Test can be ordered through this is my: genetics to determine a baby’s risk for 87 inherited disorders, as well as providing personalised genetic information on the likely response of 32 paediatric drugs.